Influence of Specific Gravity and Food on Movement of Granules in the Gastrointestinal Tract of Rats
スポンサーリンク
概要
- 論文の詳細を見る
The suitability of rats as an animal model for estimating the bioavailability of controlled-release granules in humans was investigated. Non-disintegrating granules (diameter of 0.8 mm; specific gravity of 0.9-1.85) were used as a model preparation. Twenty granules were administered to fed rats, fasted rats and rats given soft food, and the number of granules remaining in the gastrointestinal tract was counted at suitable intervals.Granules with a specific gravity of 1.25 administered to fasted rats were rapidly emptied from the stomach with a 50% gastric emptying time of 1 h as compared with granules with a specific gravity of less than 1.0 or with a high specific gravity such as 1.85. The presence of food in the stomach reduced the emptying rate of granyles. The mean transit time of granules through the small intestinal tract was not influenced by the specific gravity or the presence of food. The mean transit time was about 3 h.It was found that the transit profile of granules through the gastrointestinal tract in rats was similar to that of granules in humans. Accordingly, it is possible to use rats at the preformulation stage for estimating the bioavailability of controlled-release granules in humans.
- 社団法人日本薬学会の論文
- 1989-03-25
著者
-
中村 康彦
大日本製薬株式会社製品研究所
-
白井 寿海
大日本製薬株式会社製品研究所
-
森 正昭
大日本製薬(株)製品研究所
-
白井 寿海
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
中村 康彦
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
牧田 浩和
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
今里 雄
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
森 正昭
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
上園 裕子
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
高橋 照孝
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
中西 豊
Pharmaceutical Research Laboratories, Dainippon Pharmaceutical Co., Ltd.,
-
中西 豊
Research And Development Division Dainippon Pharmaceutical Co. Ltd.
-
上薗 裕子
Pharmaceutical Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
上園 裕子
Pharmaceutical Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
高橋 照孝
Research and Development Division, Dainippon Pharmaceutical Co., Ltd.,
-
高橋 照孝
Research And Development Division Dainippon Pharmaceutical Co. Ltd.
-
上園 裕子
大日本製薬
-
今里 雄
Pharmaceutical Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
牧田 浩和
Pharmaceutical Research Laboratories Dainippon Pharmaceutical Co. Ltd.
関連論文
- 難溶性薬物である脳血管障害治療薬(AJ-3941)の固体分散体顆粒の調製とその評価
- テープ接着法による素錠の接着強度とフィルム接着性の評価
- 溶解度積を用いた注射剤の輸液との配合性予測
- 破壊型速溶性コーチング散の苦味マスクと溶出への崩壊剤と熱処理の影響
- サイリウムハスクを用いたマトリックス錠からの薬物放出挙動
- Role of Low-Substituted Hydroxypropylcellulose in Dissolution and Bioavailability of Novel Fine Granule System for Masking Bitter Taste
- A Novel Fine Granule System for Masking Bitter Taste
- Particle Design of Enoxacin by Spherical Crystallizaion Technique. II. Characteristics of Agglomerated Crystals
- Particle Design of Enoxacin by Spherical Crystallization Technique. I. : Principle of Ammonia Diffusion System (ADS)
- Influence of Specific Gravity and Food on Movement of Granules in the Gastrointestinal Tract of Rats
- 糖衣錠の経時的な着色の原因と対策
- Movement of Granules and Tablets in the Gastrointestinal Tract of Gastric-Emptying-Controlled Rabbits
- 凍結乾燥注射剤の溶状不良の原因
- Gastric-Acidity-Controlled Rabbits : Control of Gastric pH of Rabbits by the Use of Antacids(Pharmaceutical)
- Suitable Size of Preparations to Evaluate the Bioavailability of Enteric-Coated Preparations by the Use of Gastric-Acidity-Controlled Rabbits
- Influence of Pharmaceutical Properties on Gastric Lesions Induced in Rats by AD-1590,a Non-steroidal Anti-inflammatory Drug
- Syntheses of Arenediacetic Esters and Acetonyl-Substituted Arylacetic Esters by Means of Friedel-Crafts Reaction with α-Acyl-α-chlorosulfides
- Characteristics of the Gastrointestinal Absorption of Morphine in Rats
- キトサン粉末分散水不溶性皮膜による部位特異的薬物放出システム : Chitosan Dispersed System (CDS)
- バルプロ酸ナトリウム-合成ケイ酸アルミニウム系からのウイスカーの発生と成長
- 苦味をマスクした膜破壊型コーティング細粒の製剤設計に関する研究 : スパルフロキサシン細粒の製剤化
- Design of Novel Controlled-Release Suppositories Containing Polyglycerol Ester of Fatty Acid
- Influence of Solid Fat Index in Triglyceride Suppository Bases on Drug Release
- 苦みのマスキングと徐放製剤
- Evaluation of Bioavailability of Cinnarizine Capsules by Use of Gastric-Acidity-Controlled Rabbits
- Stabilization of AD-1590,a Non-steroidal Antiinflammatory Agent, in Suppository Bases by β-Cyclodextrin Complexation
- Generality in Effects of Transmucosal Fluid Movement and Glucose on Drug Absorption from the Rat Small Intestine
- 第20回粉体に関する討論会